Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway B Li, Y Cao, G Meng, L Qian, T Xu, C Yan, O Luo, S Wang, J Wei, Y Ding, ... EBioMedicine 39, 239-254, 2019 | 188 | 2019 |
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma D Yu, X Shi, G Meng, J Chen, C Yan, Y Jiang, J Wei, Y Ding Oncotarget 6 (10), 7619, 2015 | 166 | 2015 |
Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling M Xia, P Gonzalez, C Li, G Meng, A Jiang, H Wang, Q Gao, KM Debatin, ... Journal of virology 88 (9), 5152-5164, 2014 | 128 | 2014 |
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells G Meng, M Xia, D Wang, A Chen, Y Wang, H Wang, D Yu, J Wei Oncotarget 5 (15), 6365, 2014 | 66 | 2014 |
Oncolytic measles virus enhances antitumour responses of adoptive CD8+ NKG2D+ cells in hepatocellular carcinoma treatment A Chen, Y Zhang, G Meng, D Jiang, H Zhang, M Zheng, M Xia, A Jiang, ... Scientific reports 7 (1), 5170, 2017 | 60 | 2017 |
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma G Meng, B Li, A Chen, M Zheng, T Xu, H Zhang, J Dong, J Wu, D Yu, ... British Journal of Cancer 122 (1), 111-120, 2020 | 57 | 2020 |
The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells D Wang, G Meng, M Zheng, Y Zhang, A Chen, J Wu, J Wei PLoS One 11 (11), e0166423, 2016 | 46 | 2016 |
Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus M Xia, G Meng, A Jiang, A Chen, M Dahlhaus, P Gonzalez, C Beltinger, ... Oncotarget 5 (11), 3907, 2014 | 46 | 2014 |
Multifunctional antitumor molecule 5′‐triphosphate siRNA combining glutaminase silencing and RIG‐I activation G Meng, M Xia, C Xu, D Yuan, M Schnurr, J Wei International journal of cancer 134 (8), 1958-1971, 2014 | 44 | 2014 |
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy M Xia, D Luo, J Dong, M Zheng, G Meng, J Wu, J Wei Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019 | 43 | 2019 |
Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma C Li, G Meng, L Su, A Chen, M Xia, C Xu, D Yu, A Jiang, J Wei Oncotarget 6 (3), 1544, 2014 | 40 | 2014 |
GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors Y Li, B Li, Y Xu, L Qian, T Xu, G Meng, H Li, Y Wang, L Zhang, X Jiang, ... Cancer Research 82 (18), 3223-3235, 2022 | 38 | 2022 |
Anti-angiogenic efficacy of 5′-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs D Yuan, M Xia, G Meng, C Xu, Y Song, J Wei Oncotarget 6 (30), 29664, 2015 | 30 | 2015 |
Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT) S Zuo, M Wei, B He, A Chen, S Wang, L Kong, Y Zhang, G Meng, T Xu, ... EBioMedicine 64, 2021 | 27 | 2021 |
CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma C Xu, X Lu, W Liu, A Chen, G Meng, H Zhang, B Li, Y Zhang, J Wu, J Wei Journal of Translational Medicine 16, 1-12, 2018 | 20 | 2018 |
Revealing chemical processes and kinetics of drug action within single living cells via plasmonic Raman probes SS Li, QY Guan, G Meng, XF Chang, JW Wei, P Wang, B Kang, JJ Xu, ... Scientific Reports 7 (1), 2296, 2017 | 20 | 2017 |
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model L Su, H Zhang, C Yan, A Chen, G Meng, J Wei, D Yu, Y Ding Oncotarget 7 (40), 65721, 2016 | 17 | 2016 |
Photoacoustic “nanobombs” fight against undesirable vesicular compartmentalization of anticancer drugs A Chen, C Xu, M Li, H Zhang, D Wang, M Xia, G Meng, B Kang, H Chen, ... Scientific Reports 5 (1), 15527, 2015 | 17 | 2015 |
Liver-enriched genes are associated with the prognosis of patients with hepatocellular carcinoma B Li, T Xu, C Liu, G Meng, Y Sun, L Qian, S Wang, J Wei, D Yu, Y Ding Scientific reports 8 (1), 11197, 2018 | 16 | 2018 |
Fludarabine as an adjuvant improves Newcastle Disease Virus-mediated antitumor immunity in hepatocellular carcinoma G Meng, Z Fei, M Fang, B Li, A Chen, C Xu, M Xia, D Yu, J Wei Molecular Therapy-Oncolytics 13, 22-34, 2019 | 15 | 2019 |